✦ LIBER ✦

632 POSTER Randomized phase II study of BMS-247550 (NSC 710428) given daily X 5 days or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: E2301

✍ Scribed by B. Burtness; J. Manola; A. Argiris; D. Altieri; R. Axelrod; A. Forastiere

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1029 POSTER A phase II study of sorafeni

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

408 A phase II study of erlotinib in com

✍ E. Winquist; D. Soulieres; E. Chen; M. Tsao; M. Klein; G. Pond; J. Dancey; E. Ei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase II randomized study of concomitant

✍ Robert Haddad; Lori Wirth; Rosemary Costello; Linda Weeks; Marshall Posner 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB

A phase II study of vinorelbine (VRL), c

✍ V. Guillem; M.A. Muñoz; R. Yaya; V. Soriano; M.A. Climent; C. Gaspar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 142 KB

8517 Phase I results from an open-label,

✍ Brümmendorf, T.; Guigay, J.; Mesía, R.; Trigo, J.; Keilholz, U.; Dittrich, C.; K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB